Morning Hypertension and Patient Self-monitoring
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,707
- 主要终点
- Changes in morning blood pressure (systolic and diastolic)
研究概览
简要总结
The purpose of the study was to examine the effect of six- to eight-week treatment with MicardisPlus® on blood pressure and the effect of patient self-monitoring on blood pressure control. In addition, the post-marketing surveillance study offered the possibility to obtain information about the influence on different laboratory parameters during treatment with MicardisPlus® from an unselected patient group under office conditions
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > 18 years
- •Hypertension
排除标准
- •Age < 18 years
研究组 & 干预措施
Essential hypertension
干预措施: MicardisPlus® (Drug)
结局指标
主要结局
Changes in morning blood pressure (systolic and diastolic)
时间窗: Pre-dose, up to 8 weeks after start of treatment
Changes from baseline in laboratory values
时间窗: Pre-dose, up to 8 weeks after start of treatment
Investigator assessment of efficacy on a 5-point scale
时间窗: Up to 8 weeks after start of treatment
Investigator assessment of tolerability on a 5-point scale
时间窗: Up to 8 weeks after start of treatment
Number of patients with adverse events
时间窗: Up to 8 weeks
Investigator assessment of influence on metabolism on a 3-point scale
时间窗: Up to 8 weeks after start of treatment
次要结局
未报告次要终点